首页> 外文期刊>Quantitative Imaging in Medicine and Surgery >Evaluation of bone marrow infiltration in multiple myeloma using whole-body diffusion-weighted imaging and T1-weighted water- fat separation Dixon
【24h】

Evaluation of bone marrow infiltration in multiple myeloma using whole-body diffusion-weighted imaging and T1-weighted water- fat separation Dixon

机译:使用全身扩散加权成像和T1加权水 - 脂肪分离达克松的多发性骨髓瘤骨髓浸润的评价

获取原文
           

摘要

Background: Multiple myeloma (MM) is a blood cancer caused by the unlimited proliferation of intramedullary plasma cells. The presence of focal lesions (FLs) is presumed to be a more relevant factor for patient outcomes and risk distribution than diffuse bone marrow signal abnormalities. Signal changes in these FLs also have a good correlation with prognosis. As the cell density increased, a lower apparent diffusion coefficient (ADC) value was found with the diffusion-weighted imaging (DWI) sequence. Therefore, whole-body magnetic resonance imaging (MRI) with DWI sequences is sensitive to cell density and viability and may be vital for disease detection and therapy response assessments. However, the correlation between the DWI signal and the degree of bone destruction and the proportion of bone marrow plasma cells (BMPC) was still unclear in patients with MM. Water-fat separation MRI is used mainly for evaluating liver and bone marrow fat quantification, and fat quantification in other diseases. Meanwhile, it is also possible to assess the extent of bone marrow invasion in medullary lesions. This study aimed to investigate the correlation between ADC values from whole-body DWI and water/fat MRI signals from T1-weighted water-fat separation in evaluating bone marrow infiltration in patients with MM. Methods: The study included 35 patients with MM who underwent whole-body DWI and T1-weighted water-fat separation Dixon examinations before therapy. The ADC values, normalized fat signal intensity (nMfat), normalized water molecular signal intensity (nMwater), and normalized fat fraction (nFF) of the thoracolumbar spine was measured in FLs and the normal-appearing bone marrow (NABM). The differences in values were compared using the independent-samples t -test. The correlation between ADC values and water-fat MRI signals was estimated using the Pearson or Spearman correlation test. The correlation between the MRI above parameters and proportions of BMPC was also explored. Results: Statistically significant differences were found between the mean ADC values in FLs and NABM (0.72 vs . 0.33 mm 2 /s, P0.05). The ADC value highly correlated with nMfat and nFF values and moderately with the nMwater value in FLs (r=–0.899, –0.834, 0.642, respectively, P0.0001). Correlations were also observed between the proportion of BMPC and MRI parameters in MM (r=0.984, 0.716, –0.938, and –0.905, respectively, P0.05). Conclusions: The ADC value combined with water-fat separation parameters could be used for evaluating thoracolumbar bone marrow infiltration in MM. All parameters correlated with the proportion of BMPC, which helped assess the early response in MM therapy.
机译:背景:多发性骨髓瘤(mm)是由无限血浆细胞的无限增殖引起的血癌。焦点病变(FLS)的存在被认为是患者结果和风险分布的更相关的因素,而不是弥漫性骨髓信号异常。这些FLS中的信号变化也具有与预后的良好相关性。随着细胞密度的增加,用扩散加权成像(DWI)序列发现较低表观扩散系数(ADC)值。因此,具有DWI序列的全体磁共振成像(MRI)对细胞密度和活力敏感,并且对于疾病检测和治疗响应评估可能是至关重要的。然而,DWI信号与骨破坏程度与骨髓血浆细胞(BMPC)的比例仍不清楚MM的患者仍不清楚。水脂分离MRI主要用于评估肝脏和骨髓脂肪量化,以及其他疾病的脂肪量化。同时,还可以评估髓质病变中骨髓侵袭的程度。本研究旨在探讨来自T1加权水脂肪分离的全体DWI和水/脂肪MRI信号之间ADC值与MM患者骨髓浸润中的ADC值与水/脂肪MRI信号之间的相关性。方法:该研究包括35名患者在治疗前接受全身DWI和T1加权水分离迪克松检查的患者。在FLS和胸腰椎的常规水分子强度(NMFAT),归一化水分子信号强度(NMFAT)和标准化脂肪分数(NFF)的血管肢体和正常出现的骨髓(NABM)测定。使用独立样本T -Test进行比较值的差异。使用Pearson或Spearman相关测试估计ADC值和水脂肪MRI信号之间的相关性。还探讨了上述参数与BMPC比例之间的相关性。结果:在FLS和NABM的平均ADC值之间发现统计学显着差异(0.72 Vs.0.33mm 2 / s,p0.05)。 ADC值与NMFAT和NFF值高度相关,并适度地具有FLS中的NMWATE值(R = -0.899,-0.834,0.642,分别,P <0.0001)。在MM(R = 0.984,0.716,-0.938和-0.905分别的BMPC和MRI参数的比例之间也观察到相关性之间的相关性。结论:ADC值与水脂肪分离参数相结合,可用于评估MM中的胸骨骨髓浸润。所有参数与BMPC的比例相关,有助于评估MM疗法的早期反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号